From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

UCR scientists create a fully synthetic model for growing brain cells that could allow for animal-free drug testing.

Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs. In recent years, models like ...

Artificial intelligence has been working its way into the drug development process for years now, but with little to show so far in revamping the notoriously burdensome process. While drugs are being ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader effort ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

Scientists are using machine learning to find new treatments among thousands of old medicines. Scientists are using machine learning to find new treatments among thousands of old medicines. Joseph ...

Using the Liver-on-a-chip hepatic co-culture model (assessed by CN-Bio’s partners at the US FDA), the DILI in vitro Service can screen the gene editing reagents, antibodies, small molecules, and ASO ...